We Invest in Changing Lives

Welcome to our shareholder community. Here you will find updates on our innovation pipeline progress, performance results, and corporate milestones. You’ll also have the opportunity to hear from our management team. Sign up now for Pfizer Investor Insights to receive up-to-date information about the company and your investment.

Pfizer Invests $43 Billion to Battle Cancer

Pfizer continues to invest significant capital in the next generation of potential cancer breakthroughs, having announced its proposed acquisition of Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Read more

Pfizer’s Second Quarter: Solid Financial Performance and Several Pipeline Advances

Pfizer delivered solid financial results for the second quarter of 2023, as the company executes on its goal of an unprecedented number of potential new product and indication launches while continuing to advance its pipeline. To date, Pfizer has launched eleven new products and indications, which are expected to contribute to non-COVID operational revenue growth in the second half of 2023 and beyond. Read more

Investors, Submit Your Question to Pfizer

We want to hear from you to help ensure that we are providing content that is informative and relevant.

Submit a question here about Pfizer’s R&D pipeline, Pfizer’s capital allocation objectives, or Pfizer’s roadmap for the future.

In the coming weeks and months, we’ll compile answers to common questions, giving you a way to hear from management on topics of interest to you.

Pfizer continues to advance groundbreaking work across all our therapeutics areas while delivering strong results in our innovative R&D pipeline and returning value to shareholders through dividends.

Albert Bourla
Chairman and CEO
Current Stock Price

Day High

52 Wk High

Day Low

52 Wk Low


Essential Facts and Figures for Shareholders

Get access to our latest financial information, strategy and presentations.

Join Pfizer Investor Insights

Sign up to receive important updates about Pfizer, how we’re innovating for patients and delivering value for shareholders. Email updates will also provide exciting opportunities for individual shareholders to hear from our leadership and experts.

I would like to receive information, updates, and hear from leadership regarding Pfizer Investor Insights and other investor relations initiatives in accordance with Pfizer’s Privacy Policy.